Ratings by Stifel (Benjamin Burnett)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/20/2025 | Precigen Inc. | PGEN | Maintain | Buy (Buy) |
|
Details | ||
| 3/17/2025 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (Buy) |
|
Details | ||
| 3/6/2025 | Fate Therapeutics | FATE | Maintain | Hold (N/A) |
|
Details | ||
| 2/28/2025 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2025 | Precigen Inc. | PGEN | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2025 | CRISPR Therapeutics | CRSP | Maintain | Hold (N/A) |
|
Details | ||
| 2/12/2025 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (Buy) |
|
Details | ||
| 1/27/2025 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (Buy) |
|
Details | ||
| 1/21/2025 | Atara Biotherapeutics | ATRA | Maintain | Hold (N/A) |
|
Details | ||
| 1/2/2025 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2024 | Fate Therapeutics | FATE | Maintain | Hold (N/A) |
|
Details | ||
| 11/13/2024 | Atara Biotherapeutics | ATRA | Maintain | Hold (N/A) |
|
Details | ||
| 11/11/2024 | Allogene | ALLO | Maintain | Hold (N/A) |
|
Details | ||
| 11/8/2024 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2024 | Beam Therapeutics Inc | BEAM | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2024 | Beam Therapeutics Inc | BEAM | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2024 | Fate Therapeutics | FATE | Maintain | Hold (N/A) |
|
Details | ||
| 8/9/2024 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2024 | CRISPR Therapeutics | CRSP | Maintain | Hold (N/A) |
|
Details | ||
| 6/3/2024 | Precigen Inc. | PGEN | Maintain | Buy (N/A) |
|
Details | ||
| 5/31/2024 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2024 | Allogene | ALLO | Maintain | Hold (N/A) |
|
Details | ||
| 4/1/2024 | Atara Biotherapeutics | ATRA | Maintain | Hold (N/A) |
|
Details | ||
| 2/28/2024 | Fate Therapeutics | FATE | Maintain | Hold (N/A) |
|
Details | ||
| 1/16/2024 | Beam Therapeutics Inc | BEAM | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Fate Therapeutics | FATE | Maintain | Hold (N/A) |
|
Details | ||
| 11/8/2023 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | Atara Biotherapeutics | ATRA | Maintain | Hold (N/A) |
|
Details | ||
| 9/13/2023 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2023 | Sangamo BioSciences | SGMO | Maintain | Hold (N/A) |
|
Details | ||
| 8/10/2023 | Precigen Inc. | PGEN | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | Allogene | ALLO | Maintain | Hold (N/A) |
|
Details | ||
| 7/10/2023 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 5/30/2023 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | CRISPR Therapeutics | CRSP | Maintain | Hold (N/A) |
|
Details | ||
| 5/4/2023 | Fate Therapeutics | FATE | Maintain | Hold (N/A) |
|
Details | ||
| 5/4/2023 | Allogene | ALLO | Maintain | Hold (N/A) |
|
Details | ||
| 3/7/2023 | Precigen Inc. | PGEN | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2023 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2023 | Nektar Therapeutics | NKTR | Maintain | Hold (N/A) |
|
Details | ||
| 2/24/2023 | Sangamo BioSciences | SGMO | Maintain | Hold (N/A) |
|
Details | ||
| 1/25/2023 | Precigen Inc. | PGEN | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2023 | Fate Therapeutics | FATE | Downgrade | Hold (Buy) |
11.12 (2.65) |
-76.17% | Details | |
| 11/15/2022 | Neoleukin Therapeutics | NLTX | Downgrade | Hold (Buy) |
0.54 (3.49) |
546.3% | Details | |
| 11/11/2022 | Precigen Inc. | PGEN | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Atara Biotherapeutics | ATRA | Maintain | Hold (N/A) |
|
Details | ||
| 11/7/2022 | Beam Therapeutics Inc | BEAM | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2022 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2022 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2022 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2022 | CRISPR Therapeutics | CRSP | Maintain | Hold (N/A) |
|
Details | ||
| 8/9/2022 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Global Blood Therapeutics | GBT | Downgrade | Hold (Buy) |
63.84 (68.49) |
7.28% | Details | |
| 7/22/2022 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2022 | Atara Biotherapeutics | ATRA | Downgrade | Hold (Buy) |
8.66 (9.60) |
10.85% | Details | |
| 7/5/2022 | Precigen Inc. | PGEN | Maintain | Buy (Buy) |
|
Details | ||
| 6/22/2022 | CRISPR Therapeutics | CRSP | Maintain | Hold (Hold) |
|
Details | ||
| 6/13/2022 | CRISPR Therapeutics | CRSP | Maintain | Hold (N/A) |
|
Details | ||
| 5/27/2022 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (Buy) |
|
Details | ||
| 5/20/2022 | Atara Biotherapeutics | ATRA | Maintain | Buy (Buy) |
|
Details | ||
| 5/13/2022 | CTI BioPharma | CTIC | Maintain | Buy (Buy) |
|
Details | ||
| 5/10/2022 | CRISPR Therapeutics | CRSP | Maintain | Hold (Hold) |
|
Details | ||
| 5/6/2022 | Nektar Therapeutics | NKTR | Maintain | Hold (Hold) |
|
Details | ||
| 5/6/2022 | Sangamo BioSciences | SGMO | Maintain | Hold (Hold) |
|
Details | ||
| 5/6/2022 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (Buy) |
|
Details | ||
| 5/2/2022 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2022 | Fate Therapeutics | FATE | Maintain | Buy (Buy) |
|
Details | ||
| 4/26/2022 | Nektar Therapeutics | NKTR | Maintain | Hold (Hold) |
|
Details | ||
| 4/18/2022 | Nektar Therapeutics | NKTR | Maintain | Hold (N/A) |
|
Details | ||
| 4/14/2022 | CTI BioPharma | CTIC | Maintain | Buy (Buy) |
|
Details | ||
| 4/6/2022 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (Buy) |
|
Details | ||
| 4/1/2022 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2022 | Atara Biotherapeutics | ATRA | Maintain | Buy (Buy) |
|
Details | ||
| 3/14/2022 | Nektar Therapeutics | NKTR | Downgrade | Hold (Buy) |
10.63 (76.08) |
615.71% | Details | |
| 3/14/2022 | Nektar Therapeutics | NKTR | Maintain | Buy (Buy) |
|
Details | ||
| 3/3/2022 | Precigen Inc. | PGEN | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2022 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Atara Biotherapeutics | ATRA | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2022 | CTI BioPharma | CTIC | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2022 | Beam Therapeutics Inc | BEAM | Maintain | Buy (Buy) |
|
Details | ||
| 2/24/2022 | Allogene | ALLO | Maintain | Hold (Hold) |
|
Details | ||
| 2/24/2022 | Global Blood Therapeutics | GBT | Maintain | Buy (Buy) |
|
Details | ||
| 2/18/2022 | Atara Biotherapeutics | ATRA | Maintain | Buy (Buy) |
|
Details | ||
| 2/16/2022 | CRISPR Therapeutics | CRSP | Maintain | Hold (N/A) |
|
Details | ||
| 2/8/2022 | Sangamo BioSciences | SGMO | Maintain | Hold (Hold) |
|
Details | ||
| 1/28/2022 | Iovanace Biotherapeutics | IOVA | Upgrade | Hold (Buy) |
13.83 (7.99) |
-42.23% | Details | |
| 1/28/2022 | Iovanace Biotherapeutics | IOVA | Upgrade | Buy (Hold) |
14.66 (13.83) |
-5.66% | Details | |
| 1/27/2022 | Atara Biotherapeutics | ATRA | Maintain | Buy (Buy) |
|
Details | ||
| 1/11/2022 | Allogene | ALLO | Maintain | Hold (N/A) |
|
Details | ||
| 1/6/2022 | Sangamo BioSciences | SGMO | Maintain | Hold (N/A) |
|
Details | ||
| 12/15/2021 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2021 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2021 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2021 | Allogene | ALLO | Downgrade | Hold (Buy) |
24.38 (2.23) |
-90.85% | Details | |
| 9/24/2021 | Beam Inc | BEAM | Upgrade | Buy (Hold) |
95.47 (29.07) |
-69.55% | Details | |
| 9/20/2021 | eFFECTOR Therapeutics, Inc. | EFTR | New Coverage | Hold (N/A) |
19.30 (10.47) |
-45.75% | Details | |
| 8/10/2021 | Beam Inc | BEAM | Maintain | Hold (N/A) |
|
Details | ||
| 8/6/2021 | Sangamo BioSciences | SGMO | Maintain | Hold (N/A) |
|
Details | ||
| 8/6/2021 | Nektar Therapeutics | NKTR | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2021 | Iovanace Biotherapeutics | IOVA | Maintain | Hold (N/A) |
|
Details | ||
| 8/4/2021 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2021 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2021 | Iovanace Biotherapeutics | IOVA | Maintain | Hold (N/A) |
|
Details | ||
| 6/28/2021 | Nektar Therapeutics | NKTR | Upgrade | Buy (Hold) |
17.02 (10.63) |
-37.54% | Details | |
| 6/11/2021 | Precigen Inc. | PGEN | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2021 | Iovanace Biotherapeutics | IOVA | Downgrade | Hold (Buy) |
26.97 (7.99) |
-70.37% | Details | |
| 5/19/2021 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2021 | Beam Inc | BEAM | Maintain | Hold (N/A) |
|
Details | ||
| 5/6/2021 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2021 | CTI BioPharma | CTIC | New Coverage | Buy (N/A) |
2.36 (9.09) |
285.17% | Details | |
| 4/13/2021 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2021 | Beam Inc | BEAM | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Precigen Inc. | PGEN | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2021 | Sangamo BioSciences | SGMO | Maintain | Hold (N/A) |
|
Details | ||
| 2/25/2021 | Precigen Inc. | PGEN | New Coverage | Buy (N/A) |
8.57 (7.16) |
-16.45% | Details | |
| 2/18/2021 | Nektar Therapeutics | NKTR | Maintain | Hold (N/A) |
|
Details | ||
| 1/26/2021 | Allogene | ALLO | Upgrade | Buy (Hold) |
30.76 (24.38) |
-20.74% | Details | |
| 1/6/2021 | Beam Inc | BEAM | New Coverage | Hold (N/A) |
83.14 (95.47) |
14.83% | Details | |
| 1/6/2021 | Neoleukin Therapeutics | NLTX | New Coverage | Buy (N/A) |
14.13 (0.54) |
-96.18% | Details | |
| 1/6/2021 | Nektar Therapeutics | NKTR | New Coverage | Hold (N/A) |
17.66 (76.08) |
330.8% | Details | |
| 1/6/2021 | Sangamo BioSciences | SGMO | New Coverage | Hold (N/A) |
15.92 (0.18) |
-98.87% | Details | |
| 12/21/2020 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2020 | Allogene | ALLO | Maintain | Hold (N/A) |
|
Details | ||
| 10/20/2020 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2020 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2020 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2020 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2020 | Allogene | ALLO | Maintain | Hold (N/A) |
|
Details | ||
| 5/28/2020 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2020 | Global Blood Therapeutics | GBT | New Coverage | Buy (N/A) |
80.29 (68.49) |
-14.7% | Details | |
| 4/27/2020 | Iovanace Biotherapeutics | IOVA | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2020 | bluebird bio | BLUE | Upgrade | Buy (Hold) |
47.32 (58.55) |
23.73% | Details | |
| 3/5/2020 | Allogene | ALLO | New Coverage | Hold (N/A) |
27.51 (30.76) |
11.81% | Details | |
| 3/4/2020 | Precision BioSciences Inc. | DTIL | New Coverage | Buy (N/A) |
8.00 (8.50) |
6.25% | Details | |
| 3/3/2020 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2020 | bluebird bio | BLUE | Maintain | Hold (N/A) |
|
Details | ||
| 11/1/2019 | bluebird bio | BLUE | Maintain | Hold (N/A) |
|
Details | ||
| 10/1/2019 | Fate Therapeutics | FATE | New Coverage | Buy (N/A) |
15.47 (2.65) |
-82.87% | Details | |
| 10/1/2019 | Iovanace Biotherapeutics | IOVA | New Coverage | Buy (N/A) |
17.99 (26.97) |
49.92% | Details | |
| 10/1/2019 | bluebird bio | BLUE | New Coverage | Hold (N/A) |
92.81 (47.32) |
-49.01% | Details | |
| 9/13/2019 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2019 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2019 | Atara Biotherapeutics | ATRA | New Coverage | Buy (N/A) |
24.37 (9.60) |
-60.61% | Details | |
| 5/23/2019 | Allogene | ALLO | New Coverage | Hold (N/A) |
29.12 (27.51) |
-5.53% | Details |
